These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22819112)

  • 41. Rosiglitazone reduces the inflammatory response in a model of vascular injury in rats.
    Rinaldi B; Pieri L; Donniacuo M; Cappetta D; Capuano A; Domenici L; Carnuccio R; Romagnoli P; Filippelli A; Rossi F
    Shock; 2009 Dec; 32(6):638-44. PubMed ID: 19333142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress.
    Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ
    J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pioglitazone preserves vein graft integrity in a rat aortic interposition model.
    Chen Z; Hasegawa T; Tanaka A; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):408-416.e1. PubMed ID: 20189191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation.
    Fishman AI; Green D; Lynch A; Choudhury M; Eshghi M; Konno S
    Urology; 2013 Aug; 82(2):489.e1-7. PubMed ID: 23796398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proinflammatory and Metabolic Changes Facilitate Renal Crystal Deposition in an Obese Mouse Model of Metabolic Syndrome.
    Taguchi K; Okada A; Hamamoto S; Iwatsuki S; Naiki T; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T
    J Urol; 2015 Dec; 194(6):1787-96. PubMed ID: 26192255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of pioglitazone on the expression of TLR4 in renal tissue of diabetic rats].
    Yu Y; Wu Y; Wen G; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):793-7. PubMed ID: 25108428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model.
    Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Lieske JC; Kim SH
    Kidney Int; 2011 Mar; 79(5):538-45. PubMed ID: 21085110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pioglitazone protects against cisplatin induced nephrotoxicity in rats and potentiates its anticancer activity against human renal adenocarcinoma cell lines.
    Mahmoud MF; El Shazly SM
    Food Chem Toxicol; 2013 Jan; 51():114-22. PubMed ID: 22989705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pioglitazone, a Peroxisome Proliferator-Activated Receptor x03B3; Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model.
    Sun L; Yuan Q; Xu T; Yao L; Feng J; Ma J; Wang L; Lu C; Wang D
    Cell Physiol Biochem; 2016; 38(5):1831-40. PubMed ID: 27160248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of PPAR-γ by pioglitazone attenuates oxidative stress in aging rat cerebral arteries through upregulating UCP2.
    Wang P; Li B; Cai G; Huang M; Jiang L; Pu J; Li L; Wu Q; Zuo L; Wang Q; Zhou P
    J Cardiovasc Pharmacol; 2014 Dec; 64(6):497-506. PubMed ID: 25490415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Murakami M; Morita Y; Nakayama Y; Kobara M; Nakata T
    Eur J Pharmacol; 2006 Nov; 549(1-3):124-32. PubMed ID: 16979161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis.
    Meimaridou E; Lobos E; Hothersall JS
    Am J Physiol Renal Physiol; 2006 Oct; 291(4):F731-40. PubMed ID: 16670437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat.
    Suzuki S; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Wei M; Wanibuchi H; Cohen SM
    Toxicol Sci; 2010 Feb; 113(2):349-57. PubMed ID: 19858066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes.
    Setti G; Hayward A; Dessapt C; Barone F; Buckingham R; White K; Bilous R; Hiroshi K; Gruden G; Viberti G; Gnudi L
    Am J Nephrol; 2010; 32(5):393-402. PubMed ID: 20814199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.